Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fucitol is a sugar alcohol derived from fucoidan or by the reduction of fucose. It is also known as L-fucitol and 1-deoxy-L-galactitol. Fucitol is a hexose alcohol with the molecular formula C6H14O5 and a molar mass of 166.17 g/mol[1][2][4][6]. It occurs naturally in some plants such as nutmeg and has been reported to have antibacterial activity[2]. In bacteria like Shigella flexneri and Escherichia coli K12, it can interact with enzymes such as L-fucose isomerase (fucI), which converts L-fucose into L-fuculose[1]. There are no approved pharmaceutical indications for fucitol; it is primarily used in research settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fucitol.